Association of exposure to phthalates and substitutes with infection risk among U.S. children

Yu Zhang1, Siqi Jin1, Zichuan Li2

  • 1MEEKL-AERM, College of Environmental Sciences and Engineering, and Center for Environment and Health, Peking University, Beijing, China.

Insights

Early exposure to di-isononyl phthalate (DiNP) increases infection risk in young children and adolescents. DiNP may not be a safe substitute for di(2-ethylhexyl) phthalate (DEHP) concerning immune health.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatrics

Background:

  • Early-life exposure to di(2-ethylhexyl) phthalate (DEHP) is linked to immune system issues in children.
  • Data on the immune effects of DEHP substitutes like di-isononyl phthalate (DiNP), di-isononyl cyclohexane-1,2-dicarboxylate (DiNCH), and di(2-ethylhexyl) terephthalate (DEHTP) is limited.

Purpose of the Study:

  • To investigate the association between urinary phthalate metabolite concentrations and overall infection risk in U.S. children.
  • To assess the potential risks of DEHP substitutes compared to legacy phthalates.

Main Methods:

  • Analyzed urinary concentrations of 18 phthalate metabolites in 1,989 U.S. children aged 3-19 years.
  • Utilized logistic and mixture models to examine associations between phthalate exposure and infection risk across three age groups.
  • Included analysis of legacy phthalates and newer substitutes like DiNP, DiNCH, and DEHTP.

Main Results:

  • Higher infection risk was associated with DiNP metabolites (MONP, MCOP) in young children (3-5 years) and adolescents (12-19 years).
  • Adolescents exposed to other phthalate metabolites (e.g., mono-benzyl phthalate, mono-(3-carboxypropyl) phthalate) showed increased infection odds.
  • A mixture of phthalates was linked to higher infection risk in adolescents. DiNCH showed an isolated adverse association in 6-11-year-old boys.

Conclusions:

  • Specific phthalates and phthalate mixtures may heighten children's susceptibility to infections.
  • DiNP does not appear to be a safe alternative to DEHP for immune-related outcomes.
  • Further research, including longitudinal and toxicological studies, is needed for newer substitutes like DiNCH and DEHTP.

Related Concept Videos

Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...